JPRN-UMIN000005801
Recruiting
Phase 2
A phase II study of induction chemoradiotherapy plus surgery in patients with stage III non-small cell lung cancer - A phase II study of induction chemoradiotherapy plus surgery in patients with stage III non-small cell lung cancer
Conditionson small cell lung cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- on small cell lung cancer
- Sponsor
- Toho University Omori Medical Center
- Enrollment
- 35
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •) Blood transfusion within 14 days of therapy before enrollment, and preparations are treated with hematopoietic factor, those patients treated with antithrombotic agents for thrombosis. 2\) Severe renal dysfunction, or urine protein 2\+ or more cases. 3\) Patient with severe drug allergy (anaphylaxis) 4\) Patients with active double cancer 5\) Patients with infectious diseases as a clinical problem, and suspected. 6\) Poorly controlled hypertension, or patients with diabetes. 7\) Significant ECG abnormalities, patients with heart disease as a clinical problem. 8\) Patients with a history mager of Thrombosis or thrombosis severe lung disease within one year of the merger or previous thrombosis, severe lung disease (interstitial pneumonitis, pulmonary fibrosis, severe emphysema, etc.) within one year. 9\) Patients with non\-healing traumatic fracture 10\) Patients with a history of mental disability, central nervus system disorder, cerebrovascular disease 11\) In addition, patients who are considered not to participate in the study by doctor.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Induction Chemoradiotherapy Followed by Surgical Resection for Non-Small Cell Lung Cancer Involving the Chest Wall: A Phase II TrialJPRN-UMIN000001810Central Japan Lung Study Group53
Completed
Phase 2
Induction Chemotherapy Followed by Chemoradiotherapy in Esophageal CancerNeoplasmsNCT02403531Mian XI110
Unknown
Phase 2
A Phase II study of induction chemotherapy S-1 and CDDP in patients with FDG-PET positive N2 disease of non-small cell lung cancer.JPRN-C000000358Fukushima Medical University25
Active, not recruiting
Phase 1
Chemoradiotherapy plus avelumab in locally advanced rectal cancerocally advanced rectal cancerMedDRA version: 20.0Level: PTClassification code 10038038Term: Rectal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2017-003582-10-ITG.O.N.O. - GRUPPO ONCOLOGICO DEL NORD OVEST101
Completed
Not Applicable
Phase I/II study of preoperative chemoradiotherapy with Gemcitabine and S-1 for resectable pancreatic cancerJPRN-UMIN000002649Multicenter Clinical Study Group of Osaka63